APPLICATION OF CELL ENGINEERING TECHNOLOGY TO THE TUMOUR IMMUNOTHERAPEUTIC DRUG: A REVIEW
The concept of cell engineering is frequently mentioned in recent years. It’s a comprehensive technology which is very powerful and useful. By using it, scientists can produce many kinds of proteins and other biological moleculars in large scale that are in great demand for the human being. Among th...
Gespeichert in:
| Veröffentlicht in: | Cell Biology International 2001-10, Vol.25 (10), p.1013-1015 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1015 |
|---|---|
| container_issue | 10 |
| container_start_page | 1013 |
| container_title | Cell Biology International |
| container_volume | 25 |
| creator | Chen, Z.N. Xing, J.L. Bian, H.J. Mi, L. Jiang, J.L. |
| description | The concept of cell engineering is frequently mentioned in recent years. It’s a comprehensive technology which is very powerful and useful. By using it, scientists can produce many kinds of proteins and other biological moleculars in large scale that are in great demand for the human being. Among these products, most can be used for tumor immunotherapy and have been confirmed to be very effective in tumour control or subsidiary treatment. Of them, most common and useful drugs include three sorts; tumour vaccines, cell factors and monoclonal antibodies. The paper will discuss in detail related drugs application advances in tumour immunotherapy. |
| doi_str_mv | 10.1006/cbir.2001.0753 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72181663</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S106569950190753X</els_id><sourcerecordid>72181663</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4232-682f27729af0dd3153de8fff817ba963bc2ba3bd50b69231f2e835cc7ec28f2a3</originalsourceid><addsrcrecordid>eNqFkM9vmzAAha1q09qlu_Y4-bQbmX_EBnbLmEuQCEQIUvVkgbElb0nT4mRr__saEW2nqSdb1vee9T4AbjCaY4T4V9XZYU4QwnMUMnoBrjCKWRBRxt6Nd84CHsfsEnx07qen8CLiH8AlxiyKOY6vwP1ys8mzZFlnZQHLW5iIPIeiSLNCiCorUliLZFWUeZnew7qE9UrAulmXTQWz9bopSv9QLTeiqbME_qia9BtcwkpsM3F3Dd6bduf0p_M5A82tqJNV4Lv8h3mgFoSSgEfEkDAkcWtQ31PMaK8jY0yEw66NOe0U6Vra9Qx1PCYUG6L9OqVCrUhkSEtn4MvU-zgcnk7aHeXeOqV3u_ZBH05OhgRHmHPqwfkEquHg3KCNfBzsvh1eJEZylClHmXKUKUeZPvD53Hzq9rr_h5_teWAxAX_sTr-8USeT71mBkR89A8EUs-6on__G2uGX5CENmbwrUsk4WyGyJXLr-Wjitdf42-pBOmX1g9K9HbQ6yv5g_zfhFUKqmi4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72181663</pqid></control><display><type>article</type><title>APPLICATION OF CELL ENGINEERING TECHNOLOGY TO THE TUMOUR IMMUNOTHERAPEUTIC DRUG: A REVIEW</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Chen, Z.N. ; Xing, J.L. ; Bian, H.J. ; Mi, L. ; Jiang, J.L.</creator><creatorcontrib>Chen, Z.N. ; Xing, J.L. ; Bian, H.J. ; Mi, L. ; Jiang, J.L.</creatorcontrib><description>The concept of cell engineering is frequently mentioned in recent years. It’s a comprehensive technology which is very powerful and useful. By using it, scientists can produce many kinds of proteins and other biological moleculars in large scale that are in great demand for the human being. Among these products, most can be used for tumor immunotherapy and have been confirmed to be very effective in tumour control or subsidiary treatment. Of them, most common and useful drugs include three sorts; tumour vaccines, cell factors and monoclonal antibodies. The paper will discuss in detail related drugs application advances in tumour immunotherapy.</description><identifier>ISSN: 1065-6995</identifier><identifier>EISSN: 1095-8355</identifier><identifier>DOI: 10.1006/cbir.2001.0753</identifier><identifier>PMID: 11589619</identifier><language>eng</language><publisher>Oxford, UK: Elsevier Ltd</publisher><subject>Antibodies, Monoclonal - therapeutic use ; Antigen Presentation ; Antigens, Neoplasm - immunology ; Antineoplastic Agents - therapeutic use ; Biological Factors - therapeutic use ; Cancer Vaccines ; Cell engineering technology ; Genetic Engineering ; Genetic Therapy ; Humans ; Immunologic Factors - therapeutic use ; immunotherapeutic drugs ; Neoplasms - immunology ; Neoplasms - therapy ; tumour</subject><ispartof>Cell Biology International, 2001-10, Vol.25 (10), p.1013-1015</ispartof><rights>2001 Academic Press</rights><rights>The Author(s) Journal compilation © 2001 International Federation for Cell Biology</rights><rights>Copyright 2001 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4232-682f27729af0dd3153de8fff817ba963bc2ba3bd50b69231f2e835cc7ec28f2a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1006%2Fcbir.2001.0753$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1006%2Fcbir.2001.0753$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>313,314,776,780,788,1411,27899,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11589619$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Z.N.</creatorcontrib><creatorcontrib>Xing, J.L.</creatorcontrib><creatorcontrib>Bian, H.J.</creatorcontrib><creatorcontrib>Mi, L.</creatorcontrib><creatorcontrib>Jiang, J.L.</creatorcontrib><title>APPLICATION OF CELL ENGINEERING TECHNOLOGY TO THE TUMOUR IMMUNOTHERAPEUTIC DRUG: A REVIEW</title><title>Cell Biology International</title><addtitle>Cell Biol Int</addtitle><description>The concept of cell engineering is frequently mentioned in recent years. It’s a comprehensive technology which is very powerful and useful. By using it, scientists can produce many kinds of proteins and other biological moleculars in large scale that are in great demand for the human being. Among these products, most can be used for tumor immunotherapy and have been confirmed to be very effective in tumour control or subsidiary treatment. Of them, most common and useful drugs include three sorts; tumour vaccines, cell factors and monoclonal antibodies. The paper will discuss in detail related drugs application advances in tumour immunotherapy.</description><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antigen Presentation</subject><subject>Antigens, Neoplasm - immunology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Biological Factors - therapeutic use</subject><subject>Cancer Vaccines</subject><subject>Cell engineering technology</subject><subject>Genetic Engineering</subject><subject>Genetic Therapy</subject><subject>Humans</subject><subject>Immunologic Factors - therapeutic use</subject><subject>immunotherapeutic drugs</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - therapy</subject><subject>tumour</subject><issn>1065-6995</issn><issn>1095-8355</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM9vmzAAha1q09qlu_Y4-bQbmX_EBnbLmEuQCEQIUvVkgbElb0nT4mRr__saEW2nqSdb1vee9T4AbjCaY4T4V9XZYU4QwnMUMnoBrjCKWRBRxt6Nd84CHsfsEnx07qen8CLiH8AlxiyKOY6vwP1ys8mzZFlnZQHLW5iIPIeiSLNCiCorUliLZFWUeZnew7qE9UrAulmXTQWz9bopSv9QLTeiqbME_qia9BtcwkpsM3F3Dd6bduf0p_M5A82tqJNV4Lv8h3mgFoSSgEfEkDAkcWtQ31PMaK8jY0yEw66NOe0U6Vra9Qx1PCYUG6L9OqVCrUhkSEtn4MvU-zgcnk7aHeXeOqV3u_ZBH05OhgRHmHPqwfkEquHg3KCNfBzsvh1eJEZylClHmXKUKUeZPvD53Hzq9rr_h5_teWAxAX_sTr-8USeT71mBkR89A8EUs-6on__G2uGX5CENmbwrUsk4WyGyJXLr-Wjitdf42-pBOmX1g9K9HbQ6yv5g_zfhFUKqmi4</recordid><startdate>200110</startdate><enddate>200110</enddate><creator>Chen, Z.N.</creator><creator>Xing, J.L.</creator><creator>Bian, H.J.</creator><creator>Mi, L.</creator><creator>Jiang, J.L.</creator><general>Elsevier Ltd</general><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200110</creationdate><title>APPLICATION OF CELL ENGINEERING TECHNOLOGY TO THE TUMOUR IMMUNOTHERAPEUTIC DRUG: A REVIEW</title><author>Chen, Z.N. ; Xing, J.L. ; Bian, H.J. ; Mi, L. ; Jiang, J.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4232-682f27729af0dd3153de8fff817ba963bc2ba3bd50b69231f2e835cc7ec28f2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antigen Presentation</topic><topic>Antigens, Neoplasm - immunology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Biological Factors - therapeutic use</topic><topic>Cancer Vaccines</topic><topic>Cell engineering technology</topic><topic>Genetic Engineering</topic><topic>Genetic Therapy</topic><topic>Humans</topic><topic>Immunologic Factors - therapeutic use</topic><topic>immunotherapeutic drugs</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - therapy</topic><topic>tumour</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Z.N.</creatorcontrib><creatorcontrib>Xing, J.L.</creatorcontrib><creatorcontrib>Bian, H.J.</creatorcontrib><creatorcontrib>Mi, L.</creatorcontrib><creatorcontrib>Jiang, J.L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cell Biology International</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Z.N.</au><au>Xing, J.L.</au><au>Bian, H.J.</au><au>Mi, L.</au><au>Jiang, J.L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>APPLICATION OF CELL ENGINEERING TECHNOLOGY TO THE TUMOUR IMMUNOTHERAPEUTIC DRUG: A REVIEW</atitle><jtitle>Cell Biology International</jtitle><addtitle>Cell Biol Int</addtitle><date>2001-10</date><risdate>2001</risdate><volume>25</volume><issue>10</issue><spage>1013</spage><epage>1015</epage><pages>1013-1015</pages><issn>1065-6995</issn><eissn>1095-8355</eissn><abstract>The concept of cell engineering is frequently mentioned in recent years. It’s a comprehensive technology which is very powerful and useful. By using it, scientists can produce many kinds of proteins and other biological moleculars in large scale that are in great demand for the human being. Among these products, most can be used for tumor immunotherapy and have been confirmed to be very effective in tumour control or subsidiary treatment. Of them, most common and useful drugs include three sorts; tumour vaccines, cell factors and monoclonal antibodies. The paper will discuss in detail related drugs application advances in tumour immunotherapy.</abstract><cop>Oxford, UK</cop><pub>Elsevier Ltd</pub><pmid>11589619</pmid><doi>10.1006/cbir.2001.0753</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1065-6995 |
| ispartof | Cell Biology International, 2001-10, Vol.25 (10), p.1013-1015 |
| issn | 1065-6995 1095-8355 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72181663 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Antibodies, Monoclonal - therapeutic use Antigen Presentation Antigens, Neoplasm - immunology Antineoplastic Agents - therapeutic use Biological Factors - therapeutic use Cancer Vaccines Cell engineering technology Genetic Engineering Genetic Therapy Humans Immunologic Factors - therapeutic use immunotherapeutic drugs Neoplasms - immunology Neoplasms - therapy tumour |
| title | APPLICATION OF CELL ENGINEERING TECHNOLOGY TO THE TUMOUR IMMUNOTHERAPEUTIC DRUG: A REVIEW |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A04%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=APPLICATION%20OF%20CELL%20ENGINEERING%20TECHNOLOGY%20TO%20THE%20TUMOUR%20IMMUNOTHERAPEUTIC%20DRUG:%20A%20REVIEW&rft.jtitle=Cell%20Biology%20International&rft.au=Chen,%20Z.N.&rft.date=2001-10&rft.volume=25&rft.issue=10&rft.spage=1013&rft.epage=1015&rft.pages=1013-1015&rft.issn=1065-6995&rft.eissn=1095-8355&rft_id=info:doi/10.1006/cbir.2001.0753&rft_dat=%3Cproquest_cross%3E72181663%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72181663&rft_id=info:pmid/11589619&rft_els_id=S106569950190753X&rfr_iscdi=true |